Testing effectiveness (Phase 2)Study completedNCT02099994What this trial is testingSafety & Immunogenicity of HIV Vaccines in Healthy Kenyan AdultsWho this might be right forAIDS University of Oxford 72
Not applicableStudy completedNCT02846402What this trial is testingImpact of HIV Self-testing Among Female Sex Workers in Kampala, UgandaWho this might be right forHIV Infection Harvard School of Public Health (HSPH) 960
Testing effectiveness (Phase 2)Study completedNCT02165202What this trial is testingPhase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure ProphylaxisWho this might be right forHuman Immunodeficiency Virus (HIV) PATH 136
Not applicableNot Yet RecruitingNCT06631495What this trial is testingAll-cause and Diseases-specific Mortality of High-risk HPV InfectionWho this might be right forHPV Infection Peking Union Medical College Hospital 100,000
Not applicableLooking for participantsNCT05159466What this trial is testingTulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive DonorsWho this might be right forHuman Immunodeficiency VirusEnd Stage Renal Disease Tulane University 30
Large-scale testing (Phase 3)Ended earlyNCT00004986What this trial is testingSafety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS PatientsWho this might be right forCryptosporidiosisHIV Infections Romark Laboratories L.C. 30
Not applicableUnknownNCT06578702What this trial is testingEvaluation of Intermittent Triple Therapies in Real LifeWho this might be right forHIV Infections University Hospital, Strasbourg, France 200
Early research (Phase 1)Study completedNCT00000986What this trial is testingThe Safety and Effectiveness of Interleukin-2 Plus Zidovudine in Patients With AIDS or AIDS Related ComplexWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT00056641What this trial is testingDual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected PatientsWho this might be right forHIV Infections Boehringer Ingelheim 328
Not applicableWithdrawnNCT03405194What this trial is testingSame-Day Treatment With Genvoya vs. EFV/TDF/3TCWho this might be right forHIV/AIDS Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
Testing effectiveness (Phase 2)Ended earlyNCT00865566What this trial is testingSafety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With MenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 2,504
Testing effectiveness (Phase 2)Study completedNCT00885495What this trial is testingDarunavir/Ritonavir and Rosuvastatin Pharmacokinetic StudyWho this might be right forHIV Infections University of Cincinnati 17
Early research (Phase 1)Study completedNCT00002353What this trial is testingA Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human SubjectsWho this might be right forHIV Infections United Biomedical
Large-scale testing (Phase 3)Study completedNCT03222583What this trial is testingEvaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionWho this might be right forHepatitis C Virus (HCV) AbbVie 546
Post-approval studies (Phase 4)Study completedNCT00402454What this trial is testingEvaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium TuberculosisWho this might be right forHIV Infections Sociedad Andaluza de Enfermedades Infecciosas 300
Large-scale testing (Phase 3)Study completedNCT00421551What this trial is testingStudy Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136Who this might be right forHIV Infections French National Agency for Research on AIDS and Viral Hepatitis 225
Not applicableStudy completedNCT00002029What this trial is testingLong-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 PercentWho this might be right forHIV Infections Abbott
Early research (Phase 1)Study completedNCT02059031What this trial is testingAssess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult SubjectsWho this might be right forInfection, Human Immunodeficiency Virus ViiV Healthcare 24
Not applicableLooking for participantsNCT05371353What this trial is testingImmune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV VaccineWho this might be right forHPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more Shanghai Bovax Biotechnology Co., Ltd. 600
Large-scale testing (Phase 3)Study completedNCT01418937What this trial is testingSafety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 StudyWho this might be right forInfections, Papillomavirus GlaxoSmithKline 164